Advocates have welcomed a surprise decision from Australia's drug regulator to approve two psychedelic drugs for mental health treatment, but some clinicians are concerned the decision may be premature.
Australia's Therapeutic Goods Administration (TGA) on Friday announced it had approved the prescribing of MDMA and psilocybin for the treatment mental health conditions.